SCHEMBL23344391

SCHEMBL23344391

CC(C)(C)CC(C)(C)NC(=O)C(=O)NCCCN1CC1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ GAA P10253 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ TP53 P04637 2/20 0.45
▸ USP2 O75604 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ POLB P06746 2/20 0.40
▸ DRD4 P21917 2/20 0.40
▸ CACNA1H O95180 2/20 0.39
▸ PKM P14618 1/20 0.39
▸ DRD2 P14416 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11468030 0.78 LMNA (0.40) LMNASMN1; SMN2GAAMAPTALDH1A1
SCHEMBL20407535 0.73 SMN1; SMN2 (0.56) LMNASMN1; SMN2GAAMAPTALDH1A1
SCHEMBL10721796 0.72 DRD4 (0.65) LMNASMN1; SMN2GAAMAPTALDH1A1
SCHEMBL11726248 0.72 LMNA (0.48) LMNASMN1; SMN2GAAMAPTALDH1A1
SCHEMBL5488104 0.71 KDM4E (0.57) LMNASMN1; SMN2GAAALDH1A1MAPK1
SCHEMBL861408 0.69 SMN1; SMN2 (0.59) LMNASMN1; SMN2GAAMAPTALDH1A1
SCHEMBL21985476 0.69 SMN1; SMN2 (0.59) LMNASMN1; SMN2GAAMAPTALDH1A1
SCHEMBL13655375 0.68 LMNA (0.84) LMNASMN1; SMN2GAAMAPTALDH1A1
SCHEMBL8254760 0.68 DRD2 (0.64) LMNASMN1; SMN2GAAMAPTALDH1A1
SCHEMBL11575546 0.67 ALDH1A1 (0.33) LMNASMN1; SMN2GAAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3819328-A1 THERMALLY-CONDUCTIVE CURABLE COMPOSITION 3M Innovative Properties Company (US) 2021-05-12 — — EP disclosed
Send feedback